Suzhou Bluehorse Therapeutics Co., Ltd.

This phase 2 trial tests a new treatment called LM103 TILs for people with advanced melanoma that has not responded to at least two prior therapies. The treatment uses immune cells taken from the patient's own tumor, grown in a lab, and then infused back to attack the cancer. The…

This study tests a new treatment for people with non-small cell lung cancer who have had surgery. Doctors take immune cells from the removed tumor, grow them in a lab, and give them back to the patient. The goal is to see if these cells can keep the cancer from coming back. About…